Kao WH, et al.. MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet 2008; 40:1185–1192.

• PubMed
Kao WH, . MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet 2008; 40:1185–1192.)| false
• Search Google Scholar
• Export Citation

Kopp JB, et al.. MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet 2008; 40:1175–1184.

• PubMed
Kopp JB, . MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet 2008; 40:1175–1184.)| false
• Search Google Scholar
• Export Citation

Genovese G, et al.. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 2010; 329:841–845.

• PubMed
Genovese G, . Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 2010; 329:841–845.)| false
• Search Google Scholar
• Export Citation

Tzur S, et al.. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. Hum Genet 2010; 128:345–350.

• PubMed
Tzur S, . Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. Hum Genet 2010; 128:345–350.)| false
• Search Google Scholar
• Export Citation

Papeta N, et al.. APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy. J Am Soc Nephrol 2011; 22:1991–1996.

• PubMed
Papeta N, . APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy. J Am Soc Nephrol 2011; 22:1991–1996.)| false
• Search Google Scholar
• Export Citation

Kanji Z, et al.. Genetic variation in APOL1 associates with younger age at hemodialysis initiation. J Am Soc Nephrol 2011; 22:2091–2097.

• PubMed
Kanji Z, . Genetic variation in APOL1 associates with younger age at hemodialysis initiation. J Am Soc Nephrol 2011; 22:2091–2097.)| false
• Search Google Scholar
• Export Citation

Genovese G, et al.. A risk allele for focal segmental glomerulosclerosis in African Americans is located within a region containing APOL1 and MYH9. Kidney Int 2010; 78:698–704.

• PubMed
Genovese G, . A risk allele for focal segmental glomerulosclerosis in African Americans is located within a region containing APOL1 and MYH9. Kidney Int 2010; 78:698–704.)| false
• Search Google Scholar
• Export Citation

Kopp JB, et al.. APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 2011; 22:2129–2137.

• PubMed
Kopp JB, . APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 2011; 22:2129–2137.)| false
• Search Google Scholar
• Export Citation

Vanhamme L, et al.. Apolipoprotein L-I is the trypanosome lytic factor of human serum. Nature 2003; 422:83–87.

• PubMed
Vanhamme L, . Apolipoprotein L-I is the trypanosome lytic factor of human serum. Nature 2003; 422:83–87.)| false
• Search Google Scholar
• Export Citation

Friedman DJ, et al.. Population-based risk assessment of APOL1 on renal disease. J Am Soc Nephrol, 2011; 22:2098–2105.

• PubMed
Friedman DJ, . Population-based risk assessment of APOL1 on renal disease. J Am Soc Nephrol, 2011; 22:2098–2105.)| false
• Search Google Scholar
• Export Citation

Madhavan SM, et al.. APOL1 localization in normal kidney and non-diabetic kidney disease. J Am Soc Nephrol 2011; 22:2119–2128.

• PubMed
Madhavan SM, . APOL1 localization in normal kidney and non-diabetic kidney disease. J Am Soc Nephrol 2011; 22:2119–2128.)| false
• Search Google Scholar
• Export Citation

Reeves-Daniel AM, et al.. The APOL1 gene and allograft survival after kidney transplantation. Am J Transplant 2011; 11:1025–1030.

• PubMed
Reeves-Daniel AM, . The APOL1 gene and allograft survival after kidney transplantation. Am J Transplant 2011; 11:1025–1030.)| false
• Search Google Scholar
• Export Citation